A003000 Stock Overview
Bukwang Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products in South Korea and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Bukwang Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩6,350.00 |
| 52 Week High | ₩9,000.00 |
| 52 Week Low | ₩5,460.00 |
| Beta | -0.12 |
| 1 Month Change | -1.09% |
| 3 Month Change | -3.64% |
| 1 Year Change | -20.72% |
| 3 Year Change | -69.54% |
| 5 Year Change | -57.36% |
| Change since IPO | 1,246.92% |
Recent News & Updates
Recent updates
Investors In Bukwang Pharmaceutical Co., Ltd. (KRX:003000) Should Consider This, First
Apr 03
Did Bukwang Pharmaceutical's (KRX:003000) Share Price Deserve to Gain 71%?
Mar 08Is Bukwang Pharmaceutical (KRX:003000) A Risky Investment?
Feb 10How Much Of Bukwang Pharmaceutical Co., Ltd. (KRX:003000) Do Insiders Own?
Jan 14Does It Make Sense To Buy Bukwang Pharmaceutical Co., Ltd. (KRX:003000) For Its Yield?
Dec 19Did You Miss Bukwang Pharmaceutical's (KRX:003000) 90% Share Price Gain?
Nov 23Shareholder Returns
| A003000 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 3.3% | 2.6% | 0.8% |
| 1Y | -20.7% | 6.8% | 6.3% |
Return vs Industry: A003000 underperformed the KR Pharmaceuticals industry which returned 7% over the past year.
Return vs Market: A003000 underperformed the KR Market which returned 6.6% over the past year.
Price Volatility
| A003000 volatility | |
|---|---|
| A003000 Average Weekly Movement | 5.5% |
| Pharmaceuticals Industry Average Movement | 4.5% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in KR Market | 11.7% |
| 10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A003000 has not had significant price volatility in the past 3 months.
Volatility Over Time: A003000's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1960 | 575 | Sung-Gu Lee | www.bukwang.co.kr |
Bukwang Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products in South Korea and internationally. It offers its products in oral solid dosage forms, injections, oral solutions, external solutions, and ointments. The company also provides ethical drugs, including drugs for treating diabetic peripheral neuropathy, hypothyroidism, toxic liver disease, chronic hepatitis, liver cirrhosis, and iron-deficiency anemia; over-the-counter drugs, such as fever and pain relief medication, gastrointestinal medication, cold medication, laxatives for constipation, collagen supplements, multivitamin supplements, mouthwash, topical gels, oral health supplements, and omega-3 supplements; and personal products comprising toothpastes, toothbrushes, and other oral care products; nutraceuticals; health functional foods; and quasi drugs.
Bukwang Pharmaceutical Co., Ltd. Fundamentals Summary
| A003000 fundamental statistics | |
|---|---|
| Market cap | ₩434.69b |
| Earnings (TTM) | -₩31.33b |
| Revenue (TTM) | ₩125.93b |
3.5x
P/S Ratio-13.9x
P/E RatioIs A003000 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A003000 income statement (TTM) | |
|---|---|
| Revenue | ₩125.93b |
| Cost of Revenue | ₩79.01b |
| Gross Profit | ₩46.92b |
| Other Expenses | ₩78.25b |
| Earnings | -₩31.33b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -457.67 |
| Gross Margin | 37.26% |
| Net Profit Margin | -24.88% |
| Debt/Equity Ratio | 33.5% |
How did A003000 perform over the long term?
See historical performance and comparison